CJC-1295 side effects most often reported are injection-site redness, flushing, headache, and water retention. Early human studies found no serious reactions, but long-term safety data don't exist. TelosRX explains what's known and what isn't.
CJC-1295 shows up in almost every growth hormone peptide conversation. The side effects rarely get the same attention. That's a problem, because the safety record is thinner than most people assume.
This explainer covers CJC-1295 side effects in plain language. You'll learn what the compound is, what early studies reported, which effects come from raising growth hormone itself, and who should be cautious.
What Is CJC-1295?
CJC-1295 is a lab-made peptide that mimics GHRH, or growth hormone-releasing hormone. GHRH is the signal your brain sends to your pituitary gland to release growth hormone (GH).
Natural GHRH breaks down in minutes. CJC-1295 has amino acid swaps that slow that breakdown. The result is a longer GH signal.
CJC-1295 is not FDA-approved for any human use. Its clinical development stopped years ago, and its status for pharmacy compounding has shifted during ongoing FDA review.
With DAC vs Without DAC: Why It Matters for Side Effects
"CJC-1295" can mean two different compounds. Their side-effect patterns differ because their exposure differs.
| Feature | CJC-1295 with DAC | CJC-1295 without DAC (Mod GRF 1-29) |
|---|---|---|
| Half-life | About 5.8 to 8.1 days | About 30 minutes |
| GH pattern | Long, raised baseline for days | Short pulse after each dose |
| Dosing in studies or reported protocols | Weekly or less often | Once or more daily |
| Side-effect pattern | Effects can linger for days | Effects tend to be brief |
| Human data | Small 2006 studies in healthy adults | Very limited |
DAC stands for Drug Affinity Complex. It lets the peptide latch onto albumin, a blood protein, which keeps it circulating for days. We cover the shorter version in CJC-1295 without DAC: what the research shows.
What Early Human Studies Reported
The main human data comes from two small 2006 studies. Both were published in the Journal of Clinical Endocrinology & Metabolism.
In the first, healthy adults aged 21 to 61 received CJC-1295 with DAC or placebo. A single dose raised average GH levels 2- to 10-fold for six days or more. IGF-1 rose 1.5- to 3-fold for 9 to 11 days. The authors reported no serious adverse reactions and called it "relatively well tolerated" (Teichman et al., 2006).
The second study found GH kept its natural pulsing pattern during CJC-1295 exposure. Trough GH levels rose about 7.5-fold, and IGF-1 rose about 45% (Ionescu and Frohman, 2006).
That's encouraging but limited. These were short studies in a few dozen healthy people. They weren't designed to catch rare or long-term effects.
Common CJC-1295 Side Effects
These are the effects most often described in early studies, clinical reports, and reported protocols. Most are mild and short-lived.
- Injection-site reactions. Redness, itching, swelling, or a small lump where the needle went in.
- Flushing. A warm, red face or upper body shortly after a dose. Reported more with the DAC version.
- Headache. Usually mild and early in use.
- Lightheadedness or nausea. Occasionally reported, often right after injecting.
- Fatigue or drowsiness. Some people report feeling tired after doses.
These match what's reported with other GHRH-type compounds. If a reaction gets worse over time, that's a reason to stop and check in with your provider.
Side Effects Tied to Higher Growth Hormone and IGF-1
A second group of side effects comes from the job CJC-1295 does: raising GH and IGF-1. IGF-1 (insulin-like growth factor 1) is the main hormone GH triggers in your liver.
| Effect | Why it can happen | What gets watched |
|---|---|---|
| Water retention or swelling | GH makes the kidneys hold more sodium and water | Ankle or hand puffiness, quick weight changes |
| Joint aches or stiffness | Fluid shifts and tissue effects of higher GH | New joint pain |
| Numbness or tingling in hands | Fluid can press on the wrist nerve (carpal tunnel-like) | Hand tingling, especially at night |
| Higher blood sugar | GH counters insulin's action | Fasting glucose, A1c |
| IGF-1 above range | Long-acting stimulation keeps IGF-1 raised | IGF-1 blood test |
These effects are dose- and exposure-related. That's one reason the long-acting DAC form gets more caution. The effects can't be "switched off" quickly once a dose is in.
Less Common and Theoretical Risks
Some concerns come from biology rather than observed cases. They're worth knowing, even if the data is thin.
- Immune reactions. FDA has cited a possible risk of immunogenicity, meaning the body forms antibodies against the peptide, for compounded CJC-1295. See the FDA's page on bulk substances with safety concerns.
- Cell-growth concerns. GH and IGF-1 promote cell growth. People with active cancer or a recent cancer history are usually advised to avoid GH-raising compounds.
- Heart rate and blood pressure changes. Some people report a racing heart or feeling flushed and warm.
- Unknown long-term effects. No long-term human studies exist. That's a data gap, not proof of safety.
Product Quality Is a Side-Effect Risk Too
Many CJC-1295 products online are sold as "research chemicals." They're labeled not for human use and aren't made under pharmacy standards.
That raises risks the peptide itself doesn't carry. Contamination, wrong doses, or a mislabeled compound (DAC vs no DAC) can all cause problems. Our guide on how to read a peptide COA explains what quality testing should show.
Who Should Avoid CJC-1295
Providers are generally cautious or decline in these situations:
- Active cancer or a recent cancer history
- Diabetes or significant insulin resistance that isn't well controlled
- Pregnancy or breastfeeding
- Untreated sleep apnea
- Pituitary disorders or prior pituitary surgery
- Competitive athletes; CJC-1295 is on the World Anti-Doping Agency's prohibited list
Your full medical history shapes the answer. That's why honest intake matters.
How Side Effects Are Monitored
Because CJC-1295 pushes the GH axis, providers usually want labs before and during use. Common checks include:
- Baseline IGF-1 to know your starting point.
- Fasting glucose and A1c to track blood sugar.
- Follow-up IGF-1 to catch levels running above range.
- Symptom check-ins for swelling, tingling, or joint pain.
Dosing and timing also affect side effects. Our CJC-1295 dosage and protocol guide covers how providers approach it. Nothing here is a dosing recommendation.
How It Compares With Related Peptides
CJC-1295 is often paired with ipamorelin, which works on a different receptor. Ipamorelin is known for a short, selective GH pulse with little effect on cortisol in early research. See our CJC-1295 vs ipamorelin comparison for the full breakdown.
Interested in how TelosRX approaches growth hormone peptides? See the CJC-1295 / Ipamorelin page. Compounded peptides are not FDA-approved, and any prescription is subject to medical approval by a licensed provider.
When to Contact a Provider
Most mild reactions fade on their own. Some signs deserve a prompt message to your provider, or urgent care if severe:
- Swelling in the face, lips, or throat, or trouble breathing
- Hives or a spreading rash after injecting
- Persistent numbness, tingling, or weakness in the hands
- Very high blood sugar readings, extreme thirst, or frequent urination
- Chest pain, a racing heart that doesn't settle, or fainting
- A red, hot, painful injection site that keeps getting worse
Don't keep dosing through a reaction to "see if it passes." Stop and check in. Your provider can decide whether to adjust, pause, or end use.
How TelosRX Handles Peptide Requests
TelosRX is an asynchronous telehealth service. You complete a secure online intake on your own schedule. A licensed provider reviews your history, goals, and labs.
If a peptide is appropriate and permitted under current rules, the provider may issue a prescription. If not, they'll explain why. You can message your care team any time.
Frequently Asked Questions
What are the most common CJC-1295 side effects?
The most commonly reported effects are injection-site redness or itching, facial flushing, headache, and mild lightheadedness after a dose. Effects tied to higher growth hormone, like water retention, joint aches, and hand tingling, can also occur. Early studies in healthy adults reported no serious adverse reactions, but they were small and short.
Is CJC-1295 safe?
Short 2006 studies in healthy adults found CJC-1295 relatively well tolerated, with no serious reactions reported. But there are no long-term human safety studies, and it is not FDA-approved. FDA has also flagged possible immune reactions with compounded versions. Safety depends on your history, product quality, and monitoring by a licensed provider.
Does CJC-1295 cause water retention?
It can. Raising growth hormone makes the kidneys hold onto more sodium and water. That may show up as puffy hands or ankles, a quick bump on the scale, or tight rings. It's more likely with the long-acting DAC version or higher exposure. Report persistent swelling to your provider.
Can CJC-1295 raise blood sugar?
Yes, it's possible. Growth hormone works against insulin, so raising GH and IGF-1 can nudge blood sugar up. That's why providers often check fasting glucose and A1c before and during use. People with diabetes or significant insulin resistance usually need extra caution or a different approach.
How long do CJC-1295 side effects last?
It depends on the version. CJC-1295 without DAC clears in about 30 minutes, so effects like flushing tend to be brief. The DAC version has a half-life of roughly six to eight days, so GH-related effects like swelling can linger for days after a single dose.
Is CJC-1295 with DAC riskier than without DAC?
The DAC version keeps growth hormone raised for days, so GH-related effects can build up and last longer. The no-DAC version gives short pulses that sit closer to your natural rhythm. Neither has long-term safety data. Which version, if any, fits you is a decision for a licensed provider.
TelosRX is LegitScript-certified. Compounded medications are not FDA-approved and are prepared under federal compounding regulations. Approval is subject to evaluation by a licensed provider; approval is not guaranteed. Individual results vary. TelosRX operates as an online-first, asynchronous telehealth service.
Start your private evaluation at TelosRX.